Re-Vana Therapeutics is an ocular pharmaceutical​ and drug delivery company focused on the development and commercialisation of revolutionary long-acting biodegradable drug delivery platforms to treat chronic eye diseases such as age-related macular degeneration, diabetic retinopathy, glaucoma and ocular infections.


Pharmaceutical

Re-Vana Therapeutics

Michael O’rourke

Wenrui Zhang

Sandip Gite

Peter McKenna

Jenna Hewitt

Lucy Finlay

Ravi Deevi

Patrick H O’ruane

Tom Biancardi

Thakur Raghu Raj Singh

David Waite

Advisory Team

Research Team

Leadership Team

Re-Vana Therapeutics

Org chart

Teams

Advisory Team

Research Team

Leadership Team

Similar companies